- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00202826
Study of Fluid Collection of the Chest in Children With Pneumonia
Parapneumonic Effusion in Children Study
The purpose of this study is to determine the best treatment for children with a fluid collection in the chest associated with an underlying pneumonia. Researchers generally agree that a child with a large fluid collection in the chest need to have the fluid drained in addition to anitbiotics. There have been many treatments studied in children that have been shown to be effective and safe, but the treatments have never been compared to each other in a randomized controlled study.
The optimal treatment of pediatric parapneumonic effusions remains controversial. The objective of this study is to compare the use of conventional management (antibiotics with thoracostomy tube placement) with primary thorascopic drainage (see protocol). Our hypothesis is that pediatric patients with parapneumonic effusion, regardless of pleural fluid composition and loculations, have decreased morbidity when treated with early thoroscopic adhesiolysis (VATS) compared with conservative treatment.
Study Overview
Status
Intervention / Treatment
Detailed Description
Study Type
Enrollment
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Michigan
-
Grand Rapids, Michigan, United States, 49503
- DeVos Children's Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- consecutive pediatric patients with a bacterial pneumonia and parapneumonic effusion
- community acquired disease
- children age 0 to 18 years
Exclusion Criteria:
- hospital acquired pneumonia
- thoracentesis or chest tube drainage outside hospital
- patients with incorrected cardiac disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
establish morbidity outcomes
|
duration of fever
|
number of procedures
|
days with a chest drainage device
|
total hospital days
|
Secondary Outcome Measures
Outcome Measure |
---|
Days of oxygen requirement
|
Days of narcotic use
|
Complication rate
|
Number of radiographic procedures
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: John Winters, MD, Helen DeVos Children's Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2003-181
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Community Acquired Bacterial Pneumonia
-
PfizerCompletedPneumonia, Pneumococcal | Gram-positive Bacterial Infections | Community Acquired InfectionsUnited States, Slovakia, Spain, Taiwan
-
Clarametyx Biosciences, Inc.RecruitingCommunity-acquired Pneumonia | Bacterial PneumoniaUnited States
-
Paratek Pharmaceuticals IncCompletedCommunity-acquired PneumoniaUnited States
-
Zai Lab (Hong Kong), Ltd.RecruitingCommunity-acquired Bacterial PneumoniaUnited States
-
Melinta Therapeutics, Inc.Biomedical Advanced Research and Development AuthorityTerminatedCommunity-acquired Bacterial PneumoniaSpain, United States, Philippines, Hungary, United Kingdom, Bulgaria
-
Melinta Therapeutics, Inc.CompletedCommunity-Acquired Bacterial PneumoniaUnited States, Canada
-
Albany Medical CollegeForest Laboratories; Albany College of Pharmacy and Health SciencesCompletedCommunity Acquired Bacterial PneumoniaUnited States
-
Paratek Pharmaceuticals IncActive, not recruitingCommunity-acquired Pneumonia | Bacterial PneumoniaBulgaria, Croatia, Georgia, Hungary, Poland, Russian Federation, Serbia, Ukraine
-
Durata Therapeutics Inc., an affiliate of Allergan...WithdrawnCommunity Acquired PneumoniaUnited States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownCommunity Acquired PneumoniaChina
Clinical Trials on Video Assisted Thorascopic Surgery Thoracostomy Tube Placement & Drainage
-
National Taiwan University HospitalDepartment of Health, Executive Yuan, R.O.C. (Taiwan)Unknown
-
University of Cape TownCompletedEmpyema | HaemothoraxSouth Africa
-
Xueying YangUnknown
-
Institute of Child HealthCompleted
-
Queen Fabiola Children's University HospitalUnknown
-
Dr. Wiley ChungRecruiting